findmyKOL
Clinical trialNCT03064126CompletedPhase 3Interventional

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty

SponsorBoston Scientific CorporationEnrollment440Artery Diseases, PeripheralAtherosclerosisOcclusive Arterial DiseasePeripheral Artery DiseasePlaque, Atherosclerotic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the safety and effectiveness of the Ranger™ Paclitaxel Coated Balloon for treating lesions located in the superficial femoral and proximal popliteal arteries (SFA/PPA). Long Balloon substudy: To evaluate the safety and effectiveness of the Boston Scientific Corporation (BSC) Ranger™ Paclitaxel Coated Balloon in the 120, 150 and 200 mm lengths for treating Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) lesions.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

67 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medizinische Univ.-Kliniken Graz

    Graz, Austria

  • Allgemeines Krankenhaus Akh

    Vienna, Austria

  • Hanusch-Krankenhaus

    Vienna, Austria

Belgium
  • Ziekenhuis Oost Limburg

    Genk, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Regionaal Ziekenhuis Heilig Hart Tienen

    Tienen, Belgium

Canada
  • Peter Lougheed Centre

    Calgary, Alberta, Canada

  • Hamilton General Hospital

    Hamilton, Ontario, Canada

  • Fleurimont Hospital

    Sherbrooke, Quebec, Canada

  • Hopital Saint - Francois D'Assise

    Québec, Canada

Japan
  • Kokura Memorial Hospital

    Kitakyushu, Fukuoka, Japan

  • Iwaki City Medical Center

    Iwaki, Fukushima, Japan

  • Tokeidai Memorial Hospital

    Sapporo, Hokkaido, Japan

  • Kansai Rosai Hospital

    Amagasaki, Hyōgo, Japan

  • Saiseikai Yokohama-City Eastern Hospital

    Yokohama, Kanagawa, Japan

  • Sendai Kousei Hospital

    Sendai, Miyagi, Japan

  • Kishiwada Tokushukai Hospital

    Kishiwada, Osaka, Japan

  • Kasukabe Chuo General Hospital

    Kasukabe, Saitama, Japan

  • Saiseikai Central Hospital

    Minato, Tokyo, Japan

  • Kyoto Katsura Hospital

    Kyoto, Japan

  • Morinomiya Hospital

    Osaka, Japan

  • Osaka Saiseikai Nakatsu Hospital

    Osaka, Japan

New Zealand
  • Auckland City Hospital

    Auckland, New Zealand

  • Clinical Trials Nz

    Hamilton, New Zealand

  • Middlemore Hospital

    Otahuhu, New Zealand

United States
  • Thomas Hospital

    Fairhope, Alabama, United States

  • Rocky Mountain Regional Va Medical Center

    Aurora, Colorado, United States

  • the Vascular Experts

    Stratford, Connecticut, United States

  • Christiana Hospital

    Newark, Delaware, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • South Florida Vascular Associates

    Coconut Creek, Florida, United States

  • North Florida Regional Medical Center

    Gainesville, Florida, United States

  • Mount Sinai Medical Center

    Miami Beach, Florida, United States

  • Adventhealth Orlando

    Orlando, Florida, United States

  • Adventhealth Sebring

    Sebring, Florida, United States

  • Wellstar Hospitals

    Marietta, Georgia, United States

  • Kaiser Foundation Hospitals

    Honolulu, Hawaii, United States

  • St. Joseph Hospital

    Fort Wayne, Indiana, United States

  • Community Hospital

    Munster, Indiana, United States

  • King'S Daughters Medical Center - Kentucky Heart Institute

    Ashland, Kentucky, United States

27 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Mar 2017
Primary completion
18 Nov 2019
Completion
25 Oct 2023
Last update posted
29 Oct 2024
Registered enrollment
440
Registry id
NCT03064126

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.